{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:27:44Z","timestamp":1790188064701,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30120C09617"],"award-info":[{"award-number":["75D30120C09617"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas","doi-asserted-by":"publisher","award":["CRES-20H01"],"award-info":[{"award-number":["CRES-20H01"]}],"id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>There is no prospective, US multicenter study of COVID-19\u2013associated pulmonary aspergillosis (CAPA). CAPA definitions do not differentiate invasive aspergillosis (IPA) from colonization. Validity of single mycologic test results is unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a prospective 7-center US study of mechanically ventilated adults with COVID-19 (April 2021\u2013May 2022). Mycoses Study Group (MSGERC) CAPA criteria include host and clinical factors, imaging and test results (histopathology; bronchoalveolar lavage [BAL] culture and\/or BAL or serum galactomannan-immunoassay). Proven, putative, and unlikely IPA were defined by clinical criteria. CAPA-unlikely IPA criteria included survival or negative autopsy following no\/limited antifungal treatment. IPA likelihood was estimated using sensitivity\/specificity of tests from autopsy data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CAPA incidence was 7% (14\/212). Independent CAPA risk factors were EORTC\/MSGERC host factor and cavitary lesions. Seven percent, 79%, and 14% of CAPA patients had proven, putative, and unlikely IPA, respectively. Respective estimated IPA likelihoods were 84%, 7%\u201399%, and 1%\u20138%. Overall, median estimated IPA likelihood was 30%. Patients with CAPA-unlikely IPA had a single positive BAL galactomannan-immunoassay with other negative tests. CAPA mortality (71%) was not impacted by antifungal treatment or significantly different than without CAPA. CAPA incidence was 10% and 16% by European Confederation of Medical Mycology and Public Health Wales definitions, respectively. IPA was unlikely in 75% (6\/8) and 57% (13\/23) diagnosed by these definitions but not MSGERC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CAPA is associated with high mortality, but IPA's contribution is unclear. Single positive tests are insufficient for diagnosing CAPA-IPA. IPA likelihood is best estimated by combining test results (both positive and negative).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf331","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T12:01:42Z","timestamp":1752753702000},"source":"Crossref","is-referenced-by-count":3,"title":["COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis\u2014Results of the Prospective MSG-017 Study"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-3239","authenticated-orcid":false,"given":"M Hong","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Pittsburgh , Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixto M","family":"Leal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham , Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-7589","authenticated-orcid":false,"given":"Luis","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Texas Health Medical School , Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-4710","authenticated-orcid":false,"given":"Andrej","family":"Spec","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University , St Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California- Davis , Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Patterson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Texas Health Science Center at San Antonio , San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Baddley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"McMullen","sequence":"additional","affiliation":[{"name":"Mycoses Study Group Central Unit, Division of Infectious Diseases, University of Alabama at Birmingham , Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drashti","family":"Shah","sequence":"additional","affiliation":[{"name":"Mycoses Study Group Central Unit, Division of Infectious Diseases, University of Alabama at Birmingham , Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius J","family":"Clancy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Pittsburgh , Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"McGwin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Alabama at Birmingham , Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-9931","authenticated-orcid":false,"given":"Peter G","family":"Pappas","sequence":"additional","affiliation":[{"name":"Mycoses Study Group Central Unit, Division of Infectious Diseases, University of Alabama at Birmingham , Birmingham, Alabama, USA"},{"name":"Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"2025071708013921900_ofaf331-B1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","article-title":"Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis","volume":"28","author":"Kariyawasam","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025071708013921900_ofaf331-B2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jointm.2021.07.001","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA)","volume":"1","author":"Dimopoulos","year":"2021","journal-title":"J Intensive Med"},{"key":"2025071708013921900_ofaf331-B3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025071708013921900_ofaf331-B4","doi-asserted-by":"crossref","first-page":"e0216921","DOI":"10.1128\/jcm.02169-21","article-title":"Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?","volume":"60","author":"Delliere","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2025071708013921900_ofaf331-B5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/diagnostics13010114","article-title":"A laboratory-based study on multiple biomarker testing in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): real-life data","volume":"13","author":"Lass-Florl","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2025071708013921900_ofaf331-B6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.202208-1570OC","article-title":"A pathology-based case series of influenza- and COVID-19-associated pulmonary aspergillosis: the proof is in the tissue","volume":"208","author":"Vanderbeke","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2025071708013921900_ofaf331-B7","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","article-title":"Invasive mould disease in fatal COVID-19: a systematic review of autopsies","volume":"2","author":"Kula","year":"2021","journal-title":"Lancet Microbe"},{"key":"2025071708013921900_ofaf331-B8","doi-asserted-by":"crossref","first-page":"106882","DOI":"10.1016\/j.rmed.2022.106882","article-title":"Autopsy study of fatal invasive pulmonary aspergillosis: often undiagnosed premortem","volume":"199","author":"Mudrakola","year":"2022","journal-title":"Respir Med"},{"key":"2025071708013921900_ofaf331-B9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00134-021-06510-2","article-title":"COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges","volume":"47","author":"Prattes","year":"2021","journal-title":"Intensive Care Med"},{"key":"2025071708013921900_ofaf331-B10","doi-asserted-by":"crossref","first-page":"ofac081","DOI":"10.1093\/ofid\/ofac081","article-title":"Coronavirus disease 2019-associated pulmonary aspergillosis: reframing the debate","volume":"9","author":"Clancy","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"2025071708013921900_ofaf331-B11","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19 associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025071708013921900_ofaf331-B12","first-page":"1367","article-title":"A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU","volume":"71","author":"White","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025071708013921900_ofaf331-B13","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"2025071708013921900_ofaf331-B14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025071708013921900_ofaf331-B15","doi-asserted-by":"crossref","first-page":"ofaa242","DOI":"10.1093\/ofid\/ofaa242","article-title":"Invasive aspergillosis as an under-recognized superinfection in COVID-19","volume":"7","author":"Thompson Iii","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025071708013921900_ofaf331-B16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/cid\/ciad141","article-title":"Clinical impact of polymerase chain reaction-based Aspergillus and azole resistance detection in invasive aspergillosis: a prospective multicenter study","volume":"77","author":"Huygens","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025071708013921900_ofaf331-B17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit Care"},{"key":"2025071708013921900_ofaf331-B18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11046-023-00809-y","article-title":"COVID-19 associated pulmonary aspergillosis in patients admitted to the intensive care unit: impact of antifungal prophylaxis","volume":"189","author":"Frost","year":"2024","journal-title":"Mycopathologia"},{"key":"2025071708013921900_ofaf331-B19","doi-asserted-by":"crossref","first-page":"e70023","DOI":"10.1111\/myc.70023","article-title":"Posaconazole for prevention of COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a European multicentre case-control study (POSACOVID)","volume":"68","author":"Prattes","year":"2025","journal-title":"Mycoses"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/7\/ofaf331\/63727074\/ofaf331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/7\/ofaf331\/63727074\/ofaf331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T12:01:44Z","timestamp":1752753704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf331\/8196497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf331","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,30]]},"article-number":"ofaf331"}}